Mancini Anthony Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$3.58M

Insider Activity of Mancini Anthony

According to the SEC Form 4 filings, Mancini Anthony, being in a position of

  1. See Remarks at Revolution Medicines, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 73310 shares for $10.22M,
    over all time since 2026-03-25, has bought 0 shares, and sold 73310 shares for $10.22M.

Biography of Mancini Anthony

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $10,222,94010100

Comparison of Insiders on Amount of Buys and Sells

2026-10-26SaleRevolution Medicines, Inc.
RVMD
See Remarks
2,310
0.0011%
$186.99$431,947+3.04%
2026-09-25SaleRevolution Medicines, Inc.
RVMD
See Remarks
3,121
0.0014%
$200.54$625,885-6.66%
2026-09-24SaleRevolution Medicines, Inc.
RVMD
See Remarks
587
0.0003%
$200.00$117,400-3.73%
2026-09-18SaleRevolution Medicines, Inc.
RVMD
See Remarks
1,764
0.0009%
$196.94$347,402+0.97%
2026-09-16SaleRevolution Medicines, Inc.
RVMD
See Remarks
1,774
0.0008%
$199.24$353,449-1.59%
2026-09-10SaleRevolution Medicines, Inc.
RVMD
See Remarks
15,448
0.0074%
$204.16$3.15M-4.73%
2026-06-16SaleRevolution Medicines, Inc.
RVMD
See Remarks
4,615
0.0022%
$156.12$720,490+23.11%
2026-05-26SaleRevolution Medicines, Inc.
RVMD
See Remarks
3,121
0.0015%
$153.99$480,611+22.9%
2026-04-27SaleRevolution Medicines, Inc.
RVMD
See Remarks
3,120
0.0015%
$132.41$413,129+43.01%
2026-03-25SaleRevolution Medicines, Inc.
RVMD
See Remarks
37,450
0.0192%
$95.56$3.58M+96.8%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.